Novo Nordisk and Pfizer separately released data on Monday showing that pills from the same class as Novo's increasingly popular weight loss drugs such as Wegovy are about as effective as those injected medicines.
COPENHAGEN - Novo Nordisk and Pfizer Inc separately released data on Monday showing that pills from the same class as Novo's increasingly popular weight loss drugs such as Wegovy are about as effective as those injected medicines, giving shares of both companies a boost.
Full peer-reviewed data published on Monday from a mid-stage trial showed that an oral compound developed by Pfizer resulted in weight loss similar to that of Novo's injected Ozempic in patients with type 2 diabetes, and its share rose more than 4%. The company had presented some of the data on its drug, danuglipron, at a medical meeting last year.
BMO Capital Markets analyst Evan Seigerman said the efficacy of Eli Lilly's injectable competitor Mounjaro appears to trump both oral options. Nonetheless, he said primary care physicians might be more comfortable prescribing pills than injections, which could expand the total market.Novo Nordisk said the results on its pill were statistically significant and showed superior weight loss to placebo.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk says trial of oral weight-loss drug shows significant resultNovo Nordisk said on Monday a late-stage trial of an oral version of its drug semaglutide for weight loss has shown statistically significant and superior weight loss when compared to a placebo.
Read more »
Pfizer's diabetes drug results in similar weight loss levels as Novo's OzempicPfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal.
Read more »
Pfizer Quickly Climbs to High; Pfizer Oral Weight Loss Drug May Be as Effective as, Quicker Than Novo Nordisk's Ozempic - CNBC By Investing.comPfizer Quickly Climbs to High; Pfizer Oral Weight Loss Drug May Be as Effective as, Quicker Than Novo Nordisk's Ozempic - CNBC
Read more »
'Staggering' Weight Loss With TirzepatideSubstantial reductions in body weight across BMI categories, as well as improved body composition, were achieved with tirzepatide in adults for chronic weight management, according to the latest results of the SURMOUNT-1 study.
Read more »
'Alarming' Levels of Childhood Obesity in SpainExcess weight affects 40.6% of children in Spain, and future predictions are not encouraging, say specialists.
Read more »
Toxic Fragments of Bacteria Leaking From The Gut May Drive Weight GainToxic substances leaking out from the gut can interfere with the functioning of fat cells and drive obesity, according to a recent study by a team of international researchers.
Read more »